Pharmaceutical manufacturers of Methadone

Sanofi is a global healthcare leader committed to improving lives around the world. With a strong focus on research and development, Sanofi strives to transform scientific innovation into healthcare solutions that address unmet medical needs. The company's extensive portfolio spans prescription medicines, vaccines, consumer healthcare products, and biopharmaceuticals, covering a wide range of therapeutic areas, including diabetes, cardiovascular disease, oncology, immunology, rare diseases, and vaccines.

Siegfried serves as your favored associate for comprehensive integrated pharmaceutical ingredient and drug product services with manufacturing capabilities globally. Our expertise is crucial for your venture throughout the entire lifespan. Our enthusiasm lies in creating and producing formulations. It is extraordinary for a provider of development and manufacturing services to possess such a blend of inherent technical expertise and knowledge. Pharmaceutical ingredient services entail Tailored Development and Outsourced Manufacturing for both active pharmaceutical ingredients (API) and intermediates, along with our own range of API (opiates and other regulated substances) and documentation featuring independent patented technologies. Clients utilizing our drug product services benefit from a wealth of inherited expertise in intricate oral drug delivery systems, including sterile filling, backed by in-house development, customer development and manufacturing, and a wide array of completed dosage form products. Enhancing chemical processes and formulations is our area of specialization. We collaborate closely with clients to innovate and enhance chemical processes, thus providing additional benefits and value. Siegfried operates at 11 locations globally, spanning both the Eastern and Western Hemispheres, with multi-purpose cGMP chemical manufacturing facilities in Zofingen, Switzerland; Pennsville, New Jersey, USA; Nantong, China; Minden, Germany; Saint-Vulbas, France; Evionnaz, Switzerland; and sites for manufacturing drug products in Zofingen, Switzerland; Malta; Hameln, Germany, Irvine, USA; Barberà del Vallès, Spain and El Masnou, Spain. Count on Siegfried as your preferred partner for more opportunities.

Veranova boasts over 50 years of expertise and is a frontrunner in the creation and fabrication of intricate and specialized APIs for the pharmaceutical and biotech sectors. It was previously a segment of Johnson Matthey, specializing in intricate and regulated chemical processes. The company delivers customized services throughout all phases of drug development and is split into Generics and Originators. It possesses a variety of development technologies and areas of expertise, along with a cooperative approach to API manufacturing and procedures.

Harman Finochem Limited is an India-based Pharmaceutical Company catering to its clients across the globe. Established by Mr. Bhupinder Singh Manhas in 1983, our core competencies are in manufacturing and exporting of Active Pharmaceutical Ingredients mainly Metformin HCl, Fenofibrate, Divalproex Sodium, Riboflavin Phosphate Sodium, Glycopyrrolate/Glycopyrronium bromide and more.

MNK’s Specialty Generics division provides a wide variety of high-quality generic medications, focusing on pain relief, addiction treatment, and ADHD, as well as a comprehensive range of active pharmaceutical ingredients (APIs), such as acetaminophen/paracetamol, DEA scheduled compounds, and stearates. We run the largest API facility in the United States. Discover the range of excipients available from Mallinckrodt Pharmaceuticals for use in pharmaceutical drug delivery systems (DDS).

Established in 1876 by Colonel Eli Lilly, Lilly has been dedicated to producing high-quality medications that address genuine needs in a time when unreliable potions were sold by dubious individuals. His encouragement to future generations of staff has been to continuously improve upon what they find. Over 140 years later, we remain steadfast in upholding his vision across all aspects of our operations and the individuals we cater to, beginning with those who use our medications and extending to healthcare professionals, employees, and the communities where we are situated.

Established in 1980 by microbiologist Mr. M L N Sastry, Malladi Drugs & Pharmaceuticals Ltd quickly emerged as a pioneer in the production of ephedrine and pseudoephedrine salts. Today, it holds a prominent position as a manufacturer of APIs in the cough and cold segment, as well as in therapeutic segments such as antihistamines, anti-convulsants, anti-depressants, and anxiolytics (CNS). With a vast export network spanning approximately 60 countries, the company derives over 85% of its revenue from international markets. Malladi's manufacturing units have received approval from prominent regulatory bodies including the FDA, EDQM, KFDA, and TGA.

Rusan Pharma is a fully integrated global pharmaceutical corporation specializing in addiction treatment and pain management. The company manufactures and markets a diverse range of API and finished formulations, particularly focusing on controlled (narcotic and psychotropic) substances. Rusan's facilities hold GMP approval from Health Canada, EU, TGA, ANVISA, PIC/S, WHO, Russia, and SAHPRA. Additionally, Rusan has CEP approval for various APIs including Buprenorphine, Fentanyl, Naltrexone, Methadone, Bisoprolol, and also produces Naloxone, Nalbuphine, Nalmefene, Apomorphine, Efflornithine, and Sodium Oxybate. The company also develops and manufactures a variety of transdermal patches and long-acting formulations such as depot injections and implants.

We are the largest pharmaceutical company in Slovakia with site originally established in the 1940s. Our multi-purpose headquarters is easily reachable from all central European hubs like Vienna, Prague and Budapest. We, at Saneca, are proud of our tradition and reputation. We help improve the quality of life.

Technology and innovation is the backbone of Embio’s success, which allows us to achieve a leadership position as a manufacturer of Active Pharmaceutical Ingredients (APIs), Intermediates and Speciality chemicals catering to a range of global customers in the pharmaceutical, nutraceutical, food, cosmetic, crop & plant protection segments. With 30+ years of experience in handling bacterial, fungal & Category 1 GMO bio-transformation, Embio has demonstrated an impeccable track record in creating sustainable, environmental friendly and disruptive technologies. With licenses to manufacture Schedule-1 & Schedule-2 substances, Embio is a leading global player in the domain of controlled substances, advanced intermediates & chiral molecules. Embio’s State of the Art manufacturing facility is approved by US-FDA, PMDA, KFDA, COFEPRIS & WHO-GMP. Our products & services cater to the stringent requirements of a large customer base in more than 70 countries, with a major share from regulated markets that includes originator and large multi-national companies.

Established in 1997, Temad Co. has been operating for over two decades and is recognized as one of the leading manufacturers of APIs in Iran. It is also known for its groundbreaking production of both narcotic and non-narcotic products with exceptional quality within the Middle East. In addition to adhering to Iranian GMP regulations, Temad has met the national and international standards of API manufacturing, including ISO 9001/14001/17025/45001 and OHSAS 18001. With a portfolio of over 115 pharmaceutical products, Temad ensures compliance with GMP and WHO standards as well as regulations for both narcotic and non-narcotic medications. The company proudly exports its diverse range of products to 45 countries across the globe.

elm-plastic GmbH is a German family-owned business that was established in 1969. Operating on a production area of 4500 square meters, we manufacture high-quality plastic components to a technically advanced standard with a workforce of approximately 120 employees working in three shifts. Our product line primarily comprises of packaging products for pharmaceuticals and dosing instruments for both human and veterinary medicine. Our satisfied customer base includes renowned international pharmacists and bottlers. These products are the result of longstanding collaboration between pharmacists, bottlers, users, and our development department.

Pluvia Consumer Health operates as a multinational pharmaceutical firm and is headquartered in Istanbul, Turkey. The company possesses unique molecules and expertise. Its product portfolio comprises distinct APIs and Finished Dosage Form medications focusing on opioid medications, cosmeceuticals, and nutraceutical supplements, all supported by modern processing systems. The company's ability to manufacture its products in-house, leveraging its proprietary know-how from A to Z, enables it to provide comprehensive support in documentation, formulation, and scientific matters, as well as supply high-quality products at unbeatable prices, covering various types of APIs.